Table 2 Demographic information of recipients and the corresponding matched donors in relation to engraftment of donor-derived mutations. CR, complete remission; MAC, myeloablative conditioning.

CharacteristicCategoryNo donor mutation
(n = 14)
Mutation engrafted
(n = 11)
PTest performed
Donor ageMedian (range)24 (21 to 39)36 (20 to 58)0.03Wilcoxon rank-sum test
Donor genderMale10 (71.4%)8 (72.7%)0.99Fisher’s exact test
Female4 (28.6%)3 (27.3%)
Recipient ageMedian (range)51 (27 to 65)55 (19 to 69)0.66Wilcoxon rank-sum test
Recipient genderMale13 (92.9%)7 (63.6%)0.13Fisher’s exact test
Female1 (7.1%)4 (36.4%)
Primary diseaseAML/MDS7 (50%)9 (81.8%)0.21Fisher’s exact test
Non-AML7 (50%)2 (18.2%)
Disease status prior to
transplant
CR7 (50%)5 (45.4%)0.99Fisher’s exact test
Non-CR7 (50%)5 (45.4%)
Unknown0 (0%)1 (9.1%)
ConditioningMAC8 (57.1%)7 (63.6%)0.99Fisher’s exact test
Non-MAC6 (42.9%)4 (36.4%)
HLA mismatchNo mismatch13 (92.9%)9 (81.8%)0.56Fisher’s exact test
Mismatch1 (7.1%)2 (18.2%)